Toward defining the autoimmune microbiome for type 1 diabetesOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined whether human intestinal microbes play a role in the autoimmunity that often leads to type 1 diabetes (T1D), building on prior murine and rat models linking gut bacteria to diabetes onset. Researchers used high-throughput, culture-independent sequencing approaches to profile gut bacterial communities over time. They tracked how bacterial composition and diversity changed as autoimmunity developed, comparing children who progressed to T1D-associated autoimmunity with those who did not.
Who was studied?
The subjects were young children at high genetic risk for type 1 diabetes. Autoimmune cases were compared over time against age-matched, genotype-matched, nonautoimmune control children. The abstract does not give an exact sample size, but the design followed this at-risk pediatric cohort longitudinally as they moved from infancy toward the toddler stage.
What were the most important findings?
Bacterial diversity diminished over time in children who developed autoimmunity, relative to matched nonautoimmune controls. A single species, Bacteroides ovatus, accounted for nearly 24% of the total increase in the phylum Bacteroidetes in autoimmune cases compared with controls. Conversely, a human Firmicute strain (CO19) represented nearly 20% of the increase in Firmicutes seen in controls over the same period, a pattern opposite to what was seen in cases.
What are the greatest implications of this study?
The findings support the idea that healthy infants develop increasingly stable, more diverse microbiomes as they approach toddlerhood, while children destined for autoimmunity show a different, less stable trajectory. This suggests specific microbial shifts, including loss of certain Firmicutes and expansion of Bacteroides ovatus, may be linked to the immune processes preceding type 1 diabetes. The results point toward the gut microbiome as a potential early marker or contributor to autoimmune risk in genetically susceptible children, warranting further work to define an autoimmune-associated microbiome signature.